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This study characterized human umbilical vein endothelial cell HUVEC adhesion, proliferation,
and gene expression on bilayered polyelectrolyte coatings composed of an outermost layer of
glycosaminoglycans hyaluronan, heparin, or chondroitin sulfate, with an underlying layer of
poly-L-lysine or chitosan. The proportion of cells that adhered to the various polyelectrolyte
coatings after 1 and 2 h incubations was quantiﬁed by the WST-8 assay. Interchanging poly-L-lysine
with chitosan resulted in signiﬁcant differences in cellular adhesion to the outermost
glycosaminoglycan layer after 1 h, but these differences became insigniﬁcant after 2 h. The
proliferation of HUVEC on the various bilayered polyelectrolyte coatings over 10 days was
characterized using the WST-8 assay. Regardless of whether the underlying layer was poly-L-lysine
or chitosan, HUVEC proliferation on the hyaluronan outermost layer was signiﬁcantly less than on
heparin or chondroitin sulfate. Additionally, it was observed that there was more proliferation with
poly-L-lysine as the underlying layer, compared to chitosan. Subsequently, real-time polymerase
chain reaction was used to analyze the expression of seven genes related to adhesion, migration, and
endothelial function VWF, VEGFR, VEGFA, endoglin, integrin-5, ICAM1, and ICAM2 by
HUVEC cultured on the various bilayered polyelectrolyte coatings for 3 days. With poly-L-lysine as
the underlying layer, biologically signiﬁcant differences greater than twofold in the expression of
VWF, VEGFR, VEGFA, endoglin, and ICAM1 were observed among the three
glycosaminoglycans. With chitosan as the underlying layer, all three glycosaminoglycans displayed
biologically signiﬁcant differences in the expression of VWF and VEGFR compared to the chitosan
control. CT-HA displayed the highest level of expression of VWF, whereas expression levels of
VEGFR were almost similar among the three glycosaminoglycans. © 2010 American Vacuum
Society. DOI: 10.1116/1.3483218
I. INTRODUCTION
In recent years, there has been growing interest in utiliz-
ing multilayered polyelectrolyte ﬁlms to immobilize biologi-
cally active proteins and drug-loaded nanoparticles on the
surface of biomaterial implants.1,2 These are fabricated
through layer-by-layer deposition of high molecular weight
polymers with opposing charges.3,4 A particularly promising
area for the therapeutic application of multilayered polyelec-
trolyte ﬁlms is in the coating of drug-eluting coronary stents5
as an attempt to prevent restenosis after percutaneous trans-
luminal angioplasty.6,7 For this purpose, it is essential that
the stent coating must not only be biocompatible but should
also be a surface that is conducive for the adhesion of endot-
helial cells so as to facilitate healing of the blood vessel and
prevent restenosis and thrombosis.
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Nevertheless, the interactions of endothelial cells with
various polyelectrolytes are currently not well-characterized
with respect to their biocompatibility and ability to serve as a
substratum for cellular adhesion. Of particular interest are
the various glycosaminoglycans negatively charged poly-
electrolytes together with poly-L-lysine and chitosan posi-
tively charged electrolytes. The glycosaminoglycans are a
class of high-molecular polysaccharide molecules with many
interesting biological properties. For example, heparin is
known to inhibit thrombosis8 and chondroitin sulfate has
been demonstrated to promote wound healing,9,10 while
hyaluronan is known to be a mediator of both wound-
healing and inﬂammation.11 Such biologically relevant prop-
erties would certainly be useful for incorporation within the
coatings of coronary drug-eluting stents. Indeed, there have
been numerous studies on the formulation of stent coatings
with various combinations of heparin, hyaluronan, and
chondroitin sulfate,12–16 together with chitosan17 and
poly-L-lysine.18
Hence, in this study, we fabricated bilayered polyelectro-
lyte coatings of various combinations of negatively charged
glycosaminoglycans overlaid on either positively charged
poly-L-lysine or chitosan on tissue culture polystyrene
TCPS surface. The TCPS surface, being negatively
charged, is unable to bind directly to the negatively charged
glycosaminioglycans, but must instead be bound ﬁrst to ei-
ther positively charged poly-L-lysine or chitosan prior to be-
ing overlaid with the various glycosaminoglycans. The pres-
ence of the various polyelectrolytes bound to the TCPS
surface was conﬁrmed by attenuated total reﬂection Fourier
transform infrared ATR-FTIR spectroscopy, as well as
atomic force microscopy AFM. Subsequently, the study
characterized HUVEC adhesion and proliferation on the
various polyelectrolyte coatings with the WST-8 assay. In
addition, expression proﬁles of seven gene markers VWF,
VEGFR, VEGFA, Endoglin, Integrin-5, ICAM1, and
ICAM2 related to adhesion, migration, and endothelial
functions were analyzed by quantitative real-time poly-
merase chain reaction RT-qPCR. The putative functions of
these seven gene markers are listed in Table I.
II. MATERIALS AND METHODS
A. Cell lines, culture media, and reagents
HUVECs were purchased from Lonza Inc. Walkersville,
MD. Unless otherwise stated, all reagents and chemicals
were purchased from Sigma-Aldrich Inc. St. Louis, MO, all
culture media and supplements were purchased from Lonza
Inc. Walkersville, MD, while all labware consumables were
purchased from Techno Plastic Products Inc. Trasadingen,
Switzerland.
B. HUVEC culture
HUVECs were shipped in cryovials under dry ice and
were stored immediately in liquid nitrogen upon arrival. Sub-
sequently, the cells were thawed and cultured within T-75
ﬂasks at a density of 2.0103 cells /cm2. Upon reaching
conﬂuence, the cells were detached with 0.25% w/v bovine
trypsin with 1 mM EDTA Gibo-BRL Inc., Franklin Lakes,
NJ and replated on new T-75 ﬂasks at a passage split ratio of
1:3. The culture medium utilized was endothelial growth me-
dia EGM, Cat No. CC-3121; Lonza Inc., Walkersville, MD
supplemented with 4% v/v fetal bovine serum and 0.4%
v/v bovine brain extract Cat No. CC-4133; Lonza Inc.,
Walkersville, MD. The primary explanted HUVEC cells
were at P0 upon arrival and were expanded up to P7 or P8
prior to being utilized for experiments.
TABLE I. Gene markers examined by quantitative RT-qPCR.
Gene marker Putative function References
Markers of endothelial functionality
VEGFA
A key cytokine/growth factor involved in
the regulation of angiogenesis Ylä-Herttuala et al.a
VEGFR VEGF receptor Smadja et al.b
Von Willebrand Factor
VWF Platelet adhesion to wound sites: binding to factor VIII de Meyer et al.c
Endoglin CD105
Endothelial cell proliferation, angiogenesis, and vascular
remodeling Fonsatti et al.d
Adhesion and migration markers Integrin
5 subunit Focal adhesion points Liu et al.e
ICAM1 CD54 Cell migration Van de Stolpe et al.f
ICAM2
Expressed at the endothelial junctions, also
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C. Preparation of polyelectrolyte coatings for
endothelial adhesion and proliferation studies
Chitosan water soluble grade, 85% deacetylated,
M.W. 25 KDa, Cat No. 9012-76-4, Sinopharm Co Ltd.,
Shanghai, China and poly-L-lysine hydrobromide salt,
M.W. 20–30 KDa, Cat No. 81333, Fluka Chemie AG.,
Buchs, Switzerland were constituted in de-ionized water at a
concentration of 1 mg/ml, and subsequently coated onto
12-well culture dishes 4.8 cm2 per well, 0.2 ml per well
by incubation for 24 h at 37 °C. Subsequently, the chitosan
and poly-L-lysine coated culture dishes were rinsed three
times with phosphate buffered saline PBS prior to the ad-
dition of 0.2 ml of 1 mg/ml hyaluronan Healon-5™,
M.W. 5000 KDa, Cat No. 10–2030–15, Advanced Medical
Optics Inc., Uppsala, Sweden, heparin Cat No. H4784,
Sigma-Aldrich Inc., or chondroitin sulfate Cat No. 27042,
Sigma-Aldrich Inc.. After incubation for a further 24h at
37 °C, the culture dishes were rinsed again thrice prior to
being utilized for the endothelial adhesion or protein adsorp-
tion study. Altogether, there were eight experimental groups,
as follows: chitosan CT, chitosan-hyaluronan CT-HA,
chitosan-heparin CT-HP, chitosan-chondroitin sulfate
CT-CS, poly-L-lysine PLL, poly-L-lysine-hyaluronan
PLL-HA, poly-L-lysine-heparin PLL-HP and poly-L-
lysine-chondroitin sulfate PLL-CS.
D. ATR-FTIR characterization of polyelectrolyte
coatings
The preparation of bilayered polyelectrolyte coatings for
the purpose of ATR-FTIR was similar to what was described
previously. However, rinsing was carried out in de-ionized
water instead of PBS due to the presence of various salts in
PBS that might confound the ATR-FITR data. After rinsing,
the samples were left to air-dry for 24 h at room temperature,
prior to ATR-FITR analysis. Altogether, there were a total of
6 experimental groups including two controls for the ATR-
FITR analysis. These were PLL-HA, PLL-HP, PLL-CS,
CT-HA, CT-HP, and CT-CS; PLL and CT were controls. In
addition, 1 mg/ml solutions of HA, HP, and CS were added
directly on TCPS surfaces and left to air-dry for 24 h at room
temperature. These three samples were not rinsed, since they
were used as standards for later characterizations. ATR-FITR
analysis was carried out with the Spectrum 200 FTIR spec-
trometer Perkin Elmer Inc., Waltham, MA. All spectra were
collected at a resolution of 4 cm−1 and for 16 scans. TCPS
was scanned as background. Data at frequencies of
4000–800 cm−1 were collected. Results from each data set
were expressed as absorbance versus wave number. Unrinsed
HA, HP, and CS were scanned as standards for characteriza-
tions of the six experimental groups excluding the two
controls.
E. AFM characterization of polyelectrolyte coatings
The preparation of bilayered polyelectrolyte coatings for
the purpose of AFM was similar to what was described pre-
viously. However, rinsing was carried out in de-ionized wa-
ter and the samples were subsequently dried with nitrogen
gas. A commercial AFM instrument Dimension 3100 with
Nanoscope IIIa controller, Veeco Instruments Inc., Fremont,
CA equipped with a scanner 9090 m2 was employed.
The tapping mode in air was performed to observe the vari-
ous bilayered polyelectrolyte coatings on TCPS. Supersharp
silicon cantilevers with the normal resonance frequency of
330 kHz and spring constants of 42 Nm−1 SSS-NCH,
Nanosensors were used. All images were captured with a
scan rate at 1–2 Hz and 512512 pixel resolution.
F. HUVEC adhesion on polyelectrolyte coatings
HUVEC cells were seeded at a density of 5000 cells /cm2
on 12-well tissue culture dishes 4.8 cm2 per well for all
experimental groups. The culture media utilized was Endot-
helial Growth Medium Lonza Inc. supplemented with 4%
v/v fetal bovine serum and 0.4% v/v bovine brain extract.
The cells were allowed to attach for either 1 or 2 h within a
humidiﬁed 5% CO2 incubator set at 37 °C. Subsequently,
the unattached cells were rinsed away with PBS, and the
density of adherent cells was quantiﬁed with the cell count-
ing kit CCK-8 purchased from Dojindo Molecular Labora-
tories Inc. Kumamoto, Japan, according to the manufactur-
er’s protocol. Adherent cells were incubated for 2 h with
10% v/v WST-8 reagent19 supplemented in culture media
250 l per well of 12-well plate prior to absorbance read-
ings at 450 nm with a microplate reader. Standard curves
were established by measuring absorbance at 450 nm for
HUVEC cells at varying densities. The density of adherent
cells was calculated accordingly by reading off from the
standard curves. The percentage of adherent cells was calcu-
lated according to the formula Nadherent /Nseeding100%,
where Nadherent is the density of adherent cells after 1 or 2 h,
and Nseeding is the initial cell seeding density i.e.,
5000 cells /cm2.
G. HUVEC proliferation on polyelectrolyte coatings
HUVEC were seeded on the various polyelectrolyte coat-
ings CT, CT-HA, CT-HP, CT-CS, PLL, PLL-HA, PLL-HP,
and PLL-CS at a ﬁxed seeding density of 2500 cells /cm2
on 12-well tissue culture dishes 4.8 cm2 per well and
incubated for a period of 10 days within a humidiﬁed 5%
CO2 incubator set at 37 °C. The culture medium utilized was
endothelial growth medium Lonza Inc. supplemented with
0.4% v/v bovine brain extract. Phase-contrast microscopy
images of adherent HUVEC on the various polyelectrolyte
coatings were captured on day 1. On days 1, 5, and 10, the
density of adherent cells was quantiﬁed with the cell count-
ing kit CCK-8 purchased from Dojindo Molecular Labora-
tories Inc. Kumamoto, Japan. Adherent cells were incu-
bated for 2 h with 10% v/v WST-8 reagent19 supplemented
in culture media 250 l per well of 12-well plate prior to
absorbance readings at 450 nm with a microplate reader.
Densities of adherent cells were calculated from standard
curves.
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H. Cell culture for RT-qPCR analysis
HUVEC were seeded onto the various polyelectrolyte
coatings CT, CT-HA, CT-HP, CT-CS, PLL, PLL-HA,
PLL-HP, and PLL-CS at a ﬁxed seeding density of
2500 cells /cm2 in 12-well culture plates 4.8 cm2 per
well and cultured for 72 h in a humidiﬁed 5% CO2 incuba-
tor set at 37 °C. The culture medium utilized was endothelial
growth medium Lonza Inc. supplemented with 0.4% v/v
bovine brain extract. Subsequently, the cells were washed in
phosphate buffered saline PBS, trypsinized, and collected
by centrifugation and subsequently ﬂash-frozen in liquid ni-
trogen in 1.5 ml microcentrifuge tubes Eppendorf GmbH,
Hamburg, Germany. Cell counts within each experimental
group ranged from 50 000 to 200 000 cells.
I. RNA isolation, reverse transcription, and
quantitative real-time PCR
RNeasy Plus Micro Kit Qiagen Inc., Valencia, CA was
used to extract total RNA from the HUVECs, according to
the recommended protocol provided by the manufacturer.
The RNA collected was kept on ice and immediately used
for cDNA synthesis. Ampliﬁed RNA was reverse-transcribed
using the SuperScript ViLo cDNA synthesis kit Invitrogen
Inc., Carlsbad, CA. The reaction mixture was topped up
with DEPC-treated water to a total volume of 20 l. The
solution was incubated at 25 °C for 10 min, followed by
42 °C for 120 min, and ﬁnally at 85 °C for 5 min. The
synthesized cDNA was then further diluted to be used for
real-time PCR analysis. Each real-time PCR reaction in-
cluded 1 l of diluted cDNA solution, 8.16 l of DEPC-
treated water, 0.8 l of forward and reverse primer mix
10 M, 0.04 l of ROX reference dye, and 10 l of
SYBR GreenER real-time PCR mix Invitrogen Inc., Carls-
bad, CA. Reactions were carried out in triplicates in an Ap-
plied BioSystems 7500 real time PCR system Applied Bio-
Systems Inc., Foster City, CA under standard cycling
conditions. The endogenous control gene RPL27 60S ribo-
somal protein L27 reactions were run within every single
reaction plate in parallel with other reactions. The primer
sequences of the genes examined in this study are listed in
Table II. The gene expression data for all bilayered polyelec-
trolyte coatings that utilized CT as the underlying layer
CT-HA, CT-HP, and CT-CS were normalized against CT as
the reference sample. Likewise, the gene expression data for
all bilayered polyelectrolyte coatings that utilized PLL as the
underlying layer PLL-HA, PLL-HP, and PLL-CS were nor-
malized against PLL.
J. Statistical analysis of data
The results from the cell proliferation assay were ex-
pressed as meanstandard deviations n=3 for all data sets.
Statistical differences between data sets were assessed by the
Student’s t-test, with a p-value less than 0.05 being consid-
ered signiﬁcantly different. For the RT-qPCR analysis, a
more than twofold change in gene expression in relation to




As seen in Fig. 1, both PLL-HA and CT-HA show two
characteristic peaks at 1616 and 1413 cm−1 due to asymmet-
ric and symmetric stretching of the planar carboxyl groups
on HA respectively, as well as another characteristic peak at
1046 cm−1 related to the stretching of the carbohydrate
group on HA.20,21 For PLL-HP and CT-HP Fig. 2, a char-
acteristic peak at 1418 cm−1 related to a weaker stretching of
carboxylate groups on HP is observed.22,23 Additional char-
acteristic peaks observed at 1245 and 1028 cm−1 are due to
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the SO3 groups of HP.22,23 For PLL-CS and CT-CS Fig. 3,
distinctive peaks at 1635 cm−1 amide I band and
1242 cm−1 amide III band characteristic of CS are
observed.24 Additional characteristic peaks at 1415 and
1040 cm−1 are related to the stretching of saccharide alkyl
and alkoxyl groups on CS.25 The ATR-FITR data thus posi-
tively conﬁrmed the presence of bound glycosaminoglycan
molecules on the TCPS surface.
B. AFM
As seen in Fig. 4, AFM conﬁrms the deposition of the
various polyelectrolytes on the TCPS tissue culture polysty-
rene surface. Although there may not be complete surface
coverage, and the glycosaminoglycans may be concentrated
within isolated nanosized droplets for some samples i.e.,
Figs. 4e, 4f, and 4h, the surface coverage is relatively
homogenous as a whole within a ﬁxed 55 m2 area Fig.
4. This is much smaller than the typical dimensions of an
endothelial cell, so it can be assumed that the cells make
contact with a relatively homogenous surface for all coated
samples.
FIG. 1. Color online ATR-FTIR characterization curves for a PLL, b
CT, c HA, d PLL-HA, and e CT-HA coatings on TCPS.
FIG. 2. Color online ATR-FTIR characterization curves for a PLL, b
CT, c HP, d PLL-HP, and e CT-HP coatings on TCPS.
FIG. 3. Color online ATR-FTIR characterization curves for a PLL, b
CT, c CS, d PLL-CS, and e CT-CS coatings on TCPS.
FIG. 4. Color online AFM images of TCPS tissue culture polystyrene
coated with a blank, b PL, c CT, d PL-HA, e PL-HP, f PL-CS, g
CT-HA, h CT-HP, and i CT-CS. Scale bar represents 1.0 m.
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C. Endothelial adhesion on polyelectrolyte coatings
The percentages of adherent HUVEC on the various poly-
electrolyte coatings after incubation for 1 and 2 h are shown
in Figs. 5a and 5b, respectively. Interchanging poly-L-
lysine with chitosan resulted in signiﬁcant differences
P0.05 in the percentages of cells that adhered to the
various outermost glycosaminoglycan layer after 1 h Fig.
5a. Nevertheless, these differences became insigniﬁcant
P0.05 after 2 h Fig. 5b.
D. Endothelial proliferation on polyelectrolyte
coatings
HUVEC proliferation differed signiﬁcantly on the various
polyelectrolyte coatings Fig. 6. Regardless of whether the
underlying layer was CT or PLL, HUVEC proliferated least
on HA as the outermost layer, whereas there appeared to be
no signiﬁcant difference in HUVEC proliferation on either
HP or CS as the outermost layer. Additionally, it was ob-
served that proliferation was generally better with PLL as the
underlying layer, compared to CT, particularly during the
earlier phase of cell culture. As seen in Fig. 6b, there ap-
peared to be a lag in HUVEC proliferation on CT-HP and
CT-CS from days 1–5, which was not observed for HUVEC
proliferation on PLL-HP and PLL-CS Fig. 6a. The phase-
contrast microscopy images of adherent HUVEC on the vari-
ous polyelectrolyte coatings after 1 day of culture are shown
in Fig. 7. The cells exhibited a distinctively different mor-
phology on the HA outermost layer, regardless of whether
the underlying layer was PLL or CT. As seen in Figs. 7b
and 7f, the cells adopted a more rounded and less-
elongated morphology and had smaller spreading area on
HA, as compared to the other polyelectrolyte coatings.
E. RT-qPCR analysis
With poly-L-lysine as the underlying layer, PLL-HA ex-
hibited signiﬁcant upregulation in expression greater than
twofold of VWF, VEGFA, and ICAM1 compared to the
PLL control Fig. 8a. In the case of PLL-CS, there was
also a signiﬁcant upregulation greater than twofold of VWF
though not as dramatic as was seen for PLL-HA Fig. 8a.
For PLL-HP, there was observed to be signiﬁcant upregula-
FIG. 5. Percentages of HUVEC cells that adhere onto the various polyelec-
trolyte coatings after incubation for 1 h a and 2 h b in commercially
available endothelial growth medium, supplemented with 4% v/v fetal
bovine serum and 0.4% v/v bovine brain extract.
FIG. 6. HUVEC proliferation on bilayered polyelectrolyte coatings with a
poly-L-lysine and b chitosan as the underlying layer.
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tion greater than twofold of both VEGFR and Endoglin
compared to the PLL control. With chitosan as the underly-
ing layer Fig. 8b, biologically signiﬁcant differences
greater than twofold in the expression of VWF and VEGFR
were observed for all three glycosaminoglycans compared to
the chitosan control. CT-HA displayed the highest level of
expression of VWF, whereas expression levels of VEGFR
were almost similar among all three glycosaminoglycans.
IV. DISCUSSION
Currently, a major technical challenge faced by coronary
stents is the tendency for platelets to adhere/deposit onto the
stent surface and the resultant thrombogenesis that
occurs.
26,27 A possible strategy to overcome this problem
would be to formulate coatings that can promote optimal
attachment and growth of endothelial cells on the stent sur-
face, thereby ensuring hematocompatibility.28,29 For this pur-
pose, the class of polysaccharide molecules known as gly-
cosaminoglycans holds particular promise12–16 because many
of these molecules are known to exert a positive stimulatory
effect on angiogenesis and endothelial function.
For example, hyaluronan has been widely utilized in tis-
sue engineering applications to promote both angiogenesis
and wound-healing at the same time.30–33 Angioplasty and
subsequent stent placement inevitably result in blood vessel
injury, and because hyaluronan is known to enhance wound
healing,30–33 it would therefore be a suitable candidate mol-
ecule for stent coating formulation.15,16,18 The stimulatory
effect of hyaluronan on angiogenesis has been reported to be
mediated by two key receptors found on endothelial cells and
their progenitors: CD44 Ref. 34 and RHAMM.35 Heparin
could be another good candidate molecule for stent coating
formulation due to its antithrombogenic properties.12,17 For
instance, heparin is known to inﬂuence angiogenesis and en-
dothelial function through binding and sequestering of vari-
ous angiogenic factors, such as VEGF Ref. 36 and
FGF-2.37 Indeed, the binding afﬁnity of heparin for angio-
genic factors has been exploited in various tissue engineering
applications for the immobilization of these proteins on bio-
material implants.38,39 Interestingly, it was also demonstrated
that binding of heparin to angiogenic factors shielded them
from enzymatic degradation.40 Although its physiological ef-
fects on endothelial function and angiogenesis have not been
as well-characterized, chondroitin sulfate has been shown to
have desirable properties as another possible candidate mol-
ecule for stent coating formulation.14 Chondroitin sulfate is
known to be the major component of arterial walls and has
FIG. 8. RT-qPCR analysis of gene markers related to adhesion, proliferation,
and endothelial functionality for HUVEC seeded on bilayered polyelectro-
lyte coatings with a poly-L-lysine and b chitosan as the underlying layer.
FIG. 7. Color online Phase-contrast microscopy images of HUVEC cultured for 24 h on a PL, b PL-HA, c PL-HP, d PL-CS, e CT, f CT-HA, g
CT-HP, and h CT-CS. Scale bar represents 200 m.
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been shown to inhibit the formation of arteriosclerotic
plaques within animal models,41 as well as enhance would
healing.9,10
Although there have already been several studies on en-
dothelial cell interaction with various glycosaminoglycan
coatings42–44 and other multilayer polyelectolyte ﬁlms,45–47
there has not yet been a systematic comparison of the adhe-
sion, proliferation, and gene expression proﬁle of endothelial
cells on various glycosaminoglycan-coated surfaces. Given
the vast potential of glycosaminoglycan-based multilayered
polyelectrolyte ﬁlms in the fabrication of stent coatings12–18
and other tissue engineering applications,8–11 it is of great
interest to determine which particular combination of gly-
cosaminoglycans with other polyelectrolytes i.e., chitosan,
poly-L-lysine would yield the most conducive substrata for
endothelial cell adhesion, proliferation, and expression of
differentiated phenotype.
In utilizing glycosaminoglycan molecules for stent coat-
ings, alternating layer-by-layer deposition of these negatively
charged polymers together with a positively charged poly-
electrolyte i.e., poly-L-lysine and chitosan is often carried
out to achieve full-surface coverage.17,18,21,48–50 This invari-
ably results in a relatively thick multilayered coating that
tends to be soft and gel-like due to the natural physiological
role of glycosaminoglycans in absorbing and retaining
water,51 as in the case of synovial ﬂuid52 and vitreous
humor.53 Generally, most mammalian cells, including endot-
helial cells, prefer a stiff rigid surface for attachment,54,55
thus a soft gel-like substrate is most often nonconducive for
cellular adhesion and subsequent growth. Indeed, apoptosis
programed cell death has been reported to manifest in
cells cultured on soft nonrigid substrates.56 It is precisely
because of this reason that there is a preference to utilize
polymers that form a stiffer, less gel-like coating on stents,
such as polystyrene-sulfonate/poly-allylamine hydrochloride
PSS/PAH,46,57–59 which does not exhibit the water-retaining
and absorbing properties of glycosaminoglycans.
Hence, previous data on endothelial cell interaction with
multilayered polyelectrolyte ﬁlms comprised of glycosami-
noglycans may, in fact, be skewed or “clouded” by the bio-
mechanical effect of low substrate rigidity of thick multilay-
ered ﬁlms. This could in turn obscure the intrinsic
physiological effects of glycosaminoglycans on endothelial
cell function. To overcome this inherent limitation of previ-
ously reported data, this study therefore investigated endot-
helial cell interaction with a relatively thin polyelectrolyte
bilayer on a rigid TCPS substrate. No doubt, there may now
be less complete surface coverage with a polyelectrolyte bi-
layer AFM data, Fig. 4, so that the cells may also sense the
underlying TCPS substrate. Nevertheless, it must be noted
that because the polyelectrolyte bilayer is relatively thin,
there is probably more or less consistent stiffness being pro-
vided by the underlying rigid TCPS substrate across all ex-
perimental groups. Hence, the intrinsic physiological effects
of the various glycosaminoglycans on endothelial cell func-
tion can now be more clearly manifested with less inﬂuence
from mechanical parameters, such as substrate rigidity. In
any case, the AFM images Fig. 4 showed that, although
isolated nanosized droplets of glycosaminoglycans may be
present for some samples, the surface coverage is relatively
homogeneous as a whole within a ﬁxed 55 m2 area,
which is much smaller than the typical dimensions of an
endothelial cell Fig. 7. Hence, it can be assumed that the
cells are sensing a relatively homogenous surface for all
coated samples.
Both ATR-FITR Figs. 1–3 and AFM Fig. 4 data posi-
tively conﬁrmed the presence of polyelectrolytes on the
coated TCPS surface. Nevertheless, it must be noted that
both the AFM and ATR-FITR data may be ﬂawed by the
rinsing procedure with de-ionized water, which could induce
partial release or restructuration of the deposited material.
Additionally, AFM of a dried sample surface may not accu-
rately reﬂect the physiological situation in vivo within an
aqueous environment. However, there is no other choice
available but to use de-ionized water to rinse the samples
followed by subsequent drying prior to AFM or ATR-FITR
analysis, or else the presence of crystallized salts i.e., if PBS
was used instead for rinsing or remaining water would be
detected on the coated surfaces, which would in turn obscure
the data.
Subsequently, the adhesion study Fig. 5 showed that in-
terchanging PLL with CT resulted in signiﬁcant differences
in cellular adhesion to the outermost glycosaminoglycan
layer only at the 1 h time-point Fig. 5a, but these differ-
ences became insigniﬁcant after 2 h Fig. 5b. By the 2 h
time-point, 90% of the seeded cells have adhered to the
various polyelectrolyte coatings Fig. 5b. The results thus
demonstrate that within the short-time frame of 2 h, endot-
helial cells adhered equally well on the various polyelectro-
lyte coatings. The question at this point was whether endot-
helial cells would also proliferate equally well on the various
polyelectrolyte coatings.
As seen in Figs. 6a and 6b, results from the prolifera-
tion study showed obvious differences in HUVEC prolifera-
tion among the various polyelectrolyte coatings. Regardless
of whether the underlying layer was poly-L-lysine or chito-
san, HUVEC proliferation on the hyaluronan outermost layer
was signiﬁcantly lower compared to heparin and chondroitin
sulfate, which were in turn not signiﬁcantly different from
each other. This is likely to be correlated with the unusual
HUVEC morphology more rounded and less elongated,
with smaller spreading area observed when cells were cul-
tured on hyaluronan Figs. 7b and 7f. Additionally, it was
observed that HUVEC proliferation was generally better
with PLL as the underlying layer instead of CT, particularly
during the earlier phase of cell culture from days 1–5.
An interesting point to note is that most of the observed
disparity among experimental groups arises during the initial
phase of culture from days 1–5. As seen in Figs. 6a and
6b, the curve gradients i.e., rate of increase in cell num-
bers varied signiﬁcantly between experimental groups only
from days 1–5; whereas from days 5–10, the curve gradients
were almost similar for all experimental groups. It is well-
known that various somatic cell types, including endothelial
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cells, typically exhibit a “lag” phase characterized by re-
duced mitotic activity during the initial period of cell culture
immediately following trypsinization and reseeding onto a
new substrate. This could be caused by various factors, as
follows: i the newly seeded cells may need time to adhere
and adjust to the new substrata before undergoing mitosis;
ii extracellular matrix and surface proteins of the newly
seeded cells may get digested by trypsin, and the cells may
need time to resynthesize these molecules before displaying
optimal proliferation rate, iii the newly seeded cells may
need time to migrate and cluster together to restore intercel-
lular contacts and paracrine signaling that are likely to be
essential for achieving optimal proliferation rate.
Because differences in endothelial proliferation on the
various polyelectrolyte coatings are most obvious during the
initial phase of cell culture, this would thus imply that some
combinations of polyelectrolytes are better than others in
mitigating the deﬁciency of mitotic activity during the puta-
tive lag phase. In particular, HUVEC appears to proliferate
best on PLL-HP and PLL-CS, and worst on either CT-HA or
PLL-HA. However, during the later phase of cell culture
from days 5–10, differences in HUVEC proliferation rates
curve gradients in Fig. 6 on the various polyelectrolyte
coatings are diminished, probably because by then, the cells
would have already overcome their initial deﬁcit in paracrine
signaling, intercellular contacts, and extracellular matrix
synthesis.
The results of the RT-qPCR analysis showed that with
poly-L-lysine as the underlying layer Fig. 8a, PLL-HA
exhibited higher expression of VWF, VEGFA, and ICAM1
compared to PLL-HP and PLL-CS. VWF is a secreted blood
glycoprotein involved in hemostasis60–62 and plays an impor-
tant role in stopping the bleeding process during blood vessel
injury. VEGFA is a key cytokine involved in the regulation
of angiogenesis,63 while ICAM1 is a gene marker for cell
migration.64 Both endothelial migration and homeostasis are
key processes in the repair of damaged blood vessels. Hence,
the higher expression of VWF, VEGFA, and ICAM1 on
PLL-HA compared to PLL-HP and PLL-CS may somehow
be correlated with its well-known role in angiogenesis and
the repair of damaged blood vessels.65,66 Additionally, it was
also observed that PLL-HP displayed higher expression of
endoglin and VEGFR compared to PLL-HA and PLL-CS
Fig. 8a. Both VEGFR and endoglin are well-known
markers of angiogenesis.67,68 Hence the observed upregula-
tion of these two genes on PLL-HP maybe related to the
reported stimulatory effects of heparin on angiogenesis.69,70
With chitosan as the underlying layer Fig. 8b, it was
observed that the expression of VWF and VEGFR on all
three glycosaminoglycans outermost coatings were signiﬁ-
cantly higher compared to chitosan alone, although there
were no signiﬁcant differences in the expression of VEGFR
among the three glycosaminoglycan coatings on chitosan. It
is likely that because chitosan does not occur naturally in
mammalian biological systems, it is not a conducive sub-
strate for mammalian endothelial cells; hence the observed
extremely low expression levels of VWF and VEGFR on
chitosan, both of which are key markers of differentiated
endothelial cell functionality.62,67
Among the three glycosaminoglycans coatings on chito-
san, VWF is more highly expressed on CT-HA as compared
to CT-HP and CT-CS Fig. 8b. This concurs with the re-
sults obtained with poly-L-lysine as the underlying layer
Fig. 8a, and maybe related to the role of hyaluronan in the
repair of damaged blood vessels,65,66 as discussed earlier.
We have shown that polyelectrolyte coatings differ in
their interactions with HUVEC, especially during the initial
stages of the proliferative phase. Our experimental results
indicate that bilayered polyelectrolyte coatings composed of
either HP or CS with PLL would provide a favorable sub-
strate for endothelial cell proliferation.
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